Natixis Has $1.30 Million Position in The Clorox Company (NYSE:CLX)

Natixis trimmed its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 93.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,997 shares of the company's stock after selling 109,681 shares during the quarter. Natixis' holdings in Clorox were worth $1,299,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Clorox during the fourth quarter worth $26,000. Millstone Evans Group LLC acquired a new stake in shares of Clorox in the fourth quarter valued at $31,000. Asset Planning Inc bought a new position in shares of Clorox in the fourth quarter valued at about $32,000. Finally, GKV Capital Management Co. Inc. acquired a new position in Clorox during the 4th quarter worth about $32,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Up 0.5 %

Shares of Clorox stock traded up $0.63 during trading hours on Monday, reaching $138.90. 328,886 shares of the company's stock were exchanged, compared to its average volume of 1,298,602. The company has a 50 day moving average of $145.61 and a two-hundred day moving average of $155.63. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market cap of $17.11 billion, a P/E ratio of 37.97, a P/E/G ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the company posted $2.16 EPS. On average, sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.51%. Clorox's dividend payout ratio is 133.33%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on CLX shares. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Wells Fargo & Company decreased their price objective on shares of Clorox from $155.00 to $145.00 and set an "equal weight" rating for the company in a report on Wednesday, April 16th. Evercore ISI increased their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, Barclays decreased their price target on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a report on Friday, April 11th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $153.83.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.